LCN2 and cancer: LCN2 silencing also significantly reduced the percentage of cancer stem cell populations in LCN2‐silenced IBC cells relative to control, as shown by reductions in primary and secondary mammosphere formation efficiency (Fig. 3C,D) and CD44+CD24− cell subpopulations (Fig. 3E).